U.S. markets open in 3 hours 57 minutes
  • S&P Futures

    4,153.75
    +7.00 (+0.17%)
     
  • Dow Futures

    32,797.00
    +40.00 (+0.12%)
     
  • Nasdaq Futures

    13,270.75
    +42.00 (+0.32%)
     
  • Russell 2000 Futures

    1,924.50
    +2.70 (+0.14%)
     
  • Crude Oil

    88.46
    -0.55 (-0.62%)
     
  • Gold

    1,772.20
    -0.70 (-0.04%)
     
  • Silver

    20.02
    +0.18 (+0.92%)
     
  • EUR/USD

    1.0183
    -0.0004 (-0.04%)
     
  • 10-Yr Bond

    2.8400
    0.0000 (0.00%)
     
  • Vix

    21.83
    +0.39 (+1.82%)
     
  • GBP/USD

    1.2078
    +0.0008 (+0.07%)
     
  • USD/JPY

    135.0490
    +0.0790 (+0.06%)
     
  • BTC-USD

    24,130.82
    +1,175.74 (+5.12%)
     
  • CMC Crypto 200

    561.54
    +26.32 (+4.92%)
     
  • FTSE 100

    7,462.44
    +22.70 (+0.31%)
     
  • Nikkei 225

    28,249.24
    +73.37 (+0.26%)
     

Gene-Editor Crispr Therapeutics CEO Sees Positive Catalysts Ahead

·3 min read
Gene-Editor Crispr Therapeutics CEO Sees Positive Catalysts Ahead

Crispr Therapeutics Chief Executive Sam Kulkarni says the next two years of clinical trials and data readouts will give investors, and patients, plenty to cheer about.